{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:28Z","timestamp":1793317888174,"version":"4.5.0"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sj\u00f6gren\u2019s syndrome (SS) is an autoimmune disorder primarily affecting the body\u2019s exocrine glands, particularly the salivary and lacrimal glands, which lead to severe symptoms of dry eyes and mouth. The pathogenesis of SS involves the production of autoantibodies by activated immune cells, and secretion of multiple cytokines, which collectively lead to tissue damage and functional impairment. In SS, the Immune interaction among T and B cells is particularly significant. Lymphocytic infiltration in the salivary glands is predominantly composed of CD4+ T cells, whose activation cause the death of glandular epithelial cells and subsequent tissue destruction. The excessive activity of T cells contributes significantly to the disease mechanism, with helper T cells (CD4+) differentiating into various subgroups including Th1\/Th2, Th17, as well as Treg, each contributing to the pathological process through distinct cytokine secretion. In patients with SS, B cells are excessively activated, leading to substantial production of autoantibodies. These antibodies can attack self-tissues, especially the lacrimal and salivary glands, causing inflammation and tissue damage. Changes in B cell subpopulations in SS patients, such as increases in plasmablasts and plasma cells, correlate positively with serum autoantibody levels and disease progression. Therapies targeting T cells and B cells are extensively researched with the aim of alleviating symptoms and improving the quality of life for patients. Understanding how these cells promote disease development through various mechanisms, and further identifying novel T and B cell subgroups with functional characterization, will facilitate the development of more effective strategies to treat SS.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1468469","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T04:37:24Z","timestamp":1725338244000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Subpopulation dynamics of T and B lymphocytes in Sj\u00f6gren\u2019s syndrome: implications for disease activity and treatment"],"prefix":"10.3389","volume":"15","author":[{"given":"Qingliang","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann rheumatic diseases"},{"key":"B3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","article-title":"Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies","volume":"19","author":"Thorlacius","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2147\/clep.S47399","article-title":"The epidemiology of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.03.008","article-title":"Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases","volume":"14","author":"Ramos-Casals","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ajo.2015.06.004","article-title":"Ocular\u00a0complications of primary Sj\u00f6gren syndrome in men","volume":"160","author":"Mathews","year":"2015","journal-title":"Am J ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/0009922807301945","article-title":"A child with primary Sj\u00f6gren syndrome and a review of the literature","volume":"46","author":"Civilibal","year":"2007","journal-title":"Clin pediatrics"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann rheumatic diseases"},{"key":"B9","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1038\/s41598-019-45966-7","article-title":"Inhibition of cathepsin S reduces lacrimal gland inflammation and increases tear flow in a mouse model of Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Klinngam","year":"2019","journal-title":"Sci Rep"},{"key":"B10","article-title":"Genetics in Sj\u00f6gren\u2019s syndrome: where we are and where we go","author":"Harris","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215533","article-title":"Germline genetic patterns underlying familial rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren\u2019s syndrome highlight T cell-initiated autoimmunity","volume":"79","author":"Wang","year":"2020","journal-title":"Ann rheumatic diseases"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/epigenomes3030015","article-title":"Epigenetic modifications in generalized autoimmune epithelitis: Sj\u00f6gren\u2019s syndrome and primary biliary cholangitis","volume":"3","author":"Arvaniti","year":"2019","journal-title":"Epigenomes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210167","article-title":"Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Charras","year":"2017","journal-title":"Ann rheumatic diseases"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.39127","article-title":"Familial risk of Sj\u00f6gren\u2019s syndrome and co-aggregation of autoimmune diseases in affected families: A nationwide population study","volume":"67","author":"Kuo","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.06.011","article-title":"The role of intrinsic epithelial activation in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"35","author":"Manoussakis","year":"2010","journal-title":"J autoimmunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the\u00a0minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J autoimmunity"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren\u2019s syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci United States A"},{"key":"B18","doi-asserted-by":"publisher","first-page":"11742","DOI":"10.4172\/2155-9899.S1-009","article-title":"T cell-associated cytokines in the pathogenesis of Sj\u00f6gren\u2019s syndrome","author":"Jin","year":"2013","journal-title":"J Clin Cell Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12886-023-03090-1","article-title":"Primary Sj\u00f6gren\u2019s syndrome misdiagnosed as Mikulicz\u2019s disease: a case report","volume":"23","author":"Ren","year":"2023","journal-title":"BMC ophthalmol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100138","article-title":"Autoantibodies in Sj\u00f6gren\u2019s syndrome and its classification criteria","volume":"5","author":"Veenbergen","year":"2022","journal-title":"J Trans autoimmunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2020.97288","article-title":"Investigative biological therapies for primary Sj\u00f6gren\u2019s syndrome","volume":"20","author":"He","year":"2024","journal-title":"Arch Med Sci AMS"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0308-z","article-title":"The expanding functional diversity of plasma cells in immunity and inflammation","volume":"17","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.995895","article-title":"Exploiting the role of T cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome for therapeutic treatment","volume":"13","author":"An","year":"2022","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa105","article-title":"Lymphopenia in primary Sj\u00f6gren\u2019s syndrome is associated with premature aging of na\u00efve CD4+ T cells","volume":"60","author":"Fessler","year":"2021","journal-title":"Rheumatol (Oxford England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08793-7","article-title":"Immunobiology of T cells in Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Yao","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-011-9356-y","article-title":"Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sj\u00f6gren\u2019s syndrome in lupus-prone female NZB\u2009\u00d7\u2009NZWF(1) mice","volume":"35","author":"Hayashi","year":"2012","journal-title":"Inflammation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sjogren\u2019s syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J autoimmunity"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02594","article-title":"CCL22-producing resident macrophages enhance T cell response in Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Ushio","year":"2018","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1038\/s41598-019-43714-5","article-title":"Elevated cytokine levels in tears and saliva of patients with primary Sj\u00f6gren\u2019s syndrome correlate with clinical ocular and oral manifestations","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2015.1083146","article-title":"Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sj\u00f6gren\u2019s syndrome including neuromyelitis optica complicated patients","volume":"26","author":"Yoshimura","year":"2016","journal-title":"Modern Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-013-0633-0","article-title":"TNF-\u03b1 signalling and inflammation: interactions between old acquaintances","volume":"62","author":"Zelov\u00e1","year":"2013","journal-title":"Inflammation Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6252138","article-title":"Influence of interleukin-8 and neutrophil extracellular trap (NET) formation in the tumor microenvironment: is there a pathogenic role","volume":"2019","author":"Gonzalez-Aparicio","year":"2019","journal-title":"J Immunol Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681941","article-title":"The transcriptome of paired major and minor salivary gland tissue in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Verstappen","year":"2021","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157175","article-title":"Exposure of human CD4 T cells to IL-12 results in enhanced TCR-induced cytokine production, altered TCR signaling, and increased oxidative metabolism","volume":"11","author":"Vacaflores","year":"2016","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.38716","article-title":"Interleukin-6 deficiency corrects nephritis, lymphocyte abnormalities, and secondary Sj\u00f6gren\u2019s syndrome features in lupus-prone Sle1","volume":"66","author":"Maier-Moore","year":"2014","journal-title":"Yaa mice Arthritis Rheumatol (Hoboken NJ)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.945063","article-title":"Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis","volume":"13","author":"Kokubo","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.07.007","article-title":"T helper subsets in Sj\u00f6gren\u2019s syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review","volume":"51","author":"Moriyama","year":"2014","journal-title":"J autoimmunity"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000032673","article-title":"Anti-carbonic anhydrase II antibody reflects urinary acidification defect especially in proximal renal tubules in patients with primary Sj\u00f6gren syndrome","volume":"102","author":"Jin","year":"2023","journal-title":"Medicine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s11655-013-1565-9","article-title":"Effect of Chinese herbal medicine for nourishing yin, supplementing qi, and activating blood on the Th1\/Th2 immune balance in peripheral blood in patients with primary Sjogren\u2019s syndrome","volume":"19","author":"Wu","year":"2013","journal-title":"Chin J Integr Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-004-0049-9","article-title":"Increased levels of interleukin-10 in saliva of Sj\u00f6gren\u2019s syndrome patients. Correlation with disease activity","volume":"4","author":"Bertorello","year":"2004","journal-title":"Clin Exp Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2249.2012.04606.x","article-title":"Selective localization of T helper subsets in labial salivary glands from primary Sj\u00f6gren\u2019s syndrome patients","volume":"169","author":"Maehara","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2249.2012.04587.x","article-title":"Cytokine\/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sj\u00f6gren\u2019s syndrome","volume":"169","author":"Moriyama","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaut.2017.11.003","article-title":"Th17 cells in primary Sj\u00f6gren\u2019s syndrome: Pathogenicity and plasticity","volume":"87","author":"Verstappen","year":"2018","journal-title":"J autoimmunity"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2017.09.007","article-title":"Impaired anti-inflammatory activity of PPAR\u03b3 in the salivary epithelia of Sj\u00f6gren\u2019s syndrome patients imposed by intrinsic NF-\u03baB activation","volume":"86","author":"Vakrakou","year":"2018","journal-title":"J autoimmunity"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0173301","article-title":"Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep149","article-title":"Cytokine and autoantibody profiling related to histopathological features in primary Sjogren\u2019s syndrome","volume":"48","author":"Reksten","year":"2009","journal-title":"Rheumatol (Oxford England)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.022","article-title":"Unmasking the pathogenic role of IL-17 axis in primary Sj\u00f6gren\u2019s syndrome: a new era for therapeutic targeting","volume":"13","author":"Alunno","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1503315112","article-title":"IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs","volume":"112","author":"Barone","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2011.02583.x","article-title":"Expression of interleukin-22 in Sj\u00f6gren\u2019s syndrome: significant correlation with disease parameters","volume":"74","author":"Lavoie","year":"2011","journal-title":"Scandinavian J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3390\/cells12101359","article-title":"The role of regulatory T cells in the onset and progression of primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Blinova","year":"2023","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.3390\/jcm10194588","article-title":"Regulatory T-cells and multiple myeloma: implications in tumor immune biology and treatment","volume":"10","author":"Hadjiaggelidou","year":"2021","journal-title":"J Clin Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.12.004","article-title":"Th17 and regulatory T cell balance in autoimmune and inflammatory diseases","volume":"13","author":"Noack","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B57","doi-asserted-by":"publisher","first-page":"151849","DOI":"10.1016\/j.imbio.2019.09.008","article-title":"IBD: Role of intestinal compartments in the mucosal immune response","volume":"225","author":"Iacomino","year":"2020","journal-title":"Immunobiology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2017.11.026","article-title":"Autoimmune thyroid diseases and Th17\/Treg lymphocytes","volume":"192","author":"Shao","year":"2018","journal-title":"Life Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.cyto.2016.09.001","article-title":"TNF\u03b1 in the regulation of Treg and Th17 cells in rheumatoid arthritis and other autoimmune inflammatory diseases","volume":"101","author":"Bystrom","year":"2018","journal-title":"Cytokine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8813558","article-title":"The function and role of the Th17\/Treg cell balance in inflammatory bowel disease","volume":"2020","author":"Yan","year":"2020","journal-title":"J Immunol Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2012.293","article-title":"Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sj\u00f6gren\u2019s syndrome: correlation with disease activity","volume":"64","author":"Alunno","year":"2012","journal-title":"Reumatismo"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.018","article-title":"Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation","volume":"34","author":"Chaudhry","year":"2011","journal-title":"Immunity"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5mr1020-057rr","article-title":"Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Chen","year":"2021","journal-title":"J leukocyte Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/art.40424","article-title":"The ratio of blood T follicular regulatory cells to T follicular helper cells marks ectopic lymphoid structure formation while activated follicular helper T cells indicate disease activity in primary Sj\u00f6gren\u2019s syndrome","volume":"70","author":"Fonseca","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.04.133","article-title":"Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sj\u00f6gren\u2019s syndrome","volume":"422","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B67","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/cei.12703","article-title":"A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus","volume":"183","author":"Szab\u00f3","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.3390\/biom10111539","article-title":"T cells subsets in the immunopathology and treatment of Sjogren\u2019s syndrome","volume":"10","author":"R\u00edos-R\u00edos","year":"2020","journal-title":"Biomolecules"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01536","article-title":"Unexpected help: follicular regulatory T cells in the germinal center","volume":"9","author":"Xie","year":"2018","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/art.40488","article-title":"Is the T Follicular Regulatory:Follicular Helper T Cell Ratio in Blood a Biomarker for Ectopic Lymphoid Structure Formation in Sj\u00f6gren\u2019s Syndrome? Comment on the Article by Fonseca et\u00a0al","volume":"70","author":"Verstappen","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1172\/jci76861","article-title":"Circulating T follicular regulatory and helper cells have memory-like properties","volume":"124","author":"Sage","year":"2014","journal-title":"J Clin Invest"},{"key":"B73","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.smim.2015.03.001","article-title":"Global transcriptional characterization of CD8+ T cell memory","volume":"27","author":"B\u00f6ttcher","year":"2015","journal-title":"Semin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.602823","article-title":"CD8(+) T lymphocytes: crucial players in Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06098-y","article-title":"Altered levels of\u00a0circulating CD8(+)CXCR5(+)PD-1(+)T follicular cytotoxic cells in primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Zhai","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2017.38","article-title":"CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sj\u00f6gren syndrome","volume":"95","author":"Barr","year":"2017","journal-title":"Immunol Cell Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/art.40676","article-title":"Tissue-resident memory CD8+ T cells acting as mediators of salivary gland damage in a murine model of Sj\u00f6gren\u2019s syndrome","volume":"71","author":"Gao","year":"2019","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00302","article-title":"Role of innate T cells in anti-bacterial immunity","volume":"6","author":"Gao","year":"2015","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2013.863306","article-title":"Phenotypic and functional plasticity of gamma-delta (\u03b3\u03b4) T cells in inflammation and tolerance","volume":"33","author":"Paul","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.55","article-title":"Human \u03b3\u03b4T-cell subsets and their involvement in tumor immunity","volume":"14","author":"Wu","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B81","article-title":"T cells bearing gamma\/delta T cell receptor and their expression of activation antigen in peripheral blood from patients with Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Ichikawa","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"B82","article-title":"Functional characterization of T cells bearing the gamma\/delta T-cell receptor in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Gerli","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"594","DOI":"10.21037\/atm-22-1855","article-title":"Umbilical cord mesenchymal stem cells alleviate Sj\u00f6gren\u2019s syndrome and related pulmonary inflammation through regulating V\u03b34(+) IL-17(+) T cells","volume":"10","author":"Cong","year":"2022","journal-title":"Ann Trans Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.09.009","article-title":"MAIT cell development and functions: the microbial connection","volume":"53","author":"Legoux","year":"2020","journal-title":"Immunity"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02681","article-title":"A critical role for mucosal-associated invariant T cells as regulators and therapeutic targets in systemic lupus erythematosus","volume":"10","author":"Murayama","year":"2019","journal-title":"Front Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/eji.201343509","article-title":"CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner","volume":"44","author":"Ussher","year":"2014","journal-title":"Eur J Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646300","article-title":"Mucosal-associated invariant T cells are reduced and functionally immature in the peripheral blood of primary Sj\u00f6gren\u2019s syndrome patients","volume":"46","author":"Wang","year":"2016","journal-title":"Eur J Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747140","article-title":"IL-17 polarization of MAIT cells is derived from the activation of two different pathways","volume":"47","author":"Guggino","year":"2017","journal-title":"Eur J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1017157","article-title":"In patients with primary Sj\u00f6gren\u2019s syndrome innate-like MAIT cells display upregulated IL-7R, IFN-\u03b3, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells","volume":"13","author":"Hinrichs","year":"2022","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/srep14124","article-title":"CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200105)44:5<1127::Aid-anr194>3.0.Co;2-w","article-title":"Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases","volume":"44","author":"Kojo","year":"2001","journal-title":"Arthritis rheumatism"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/art.22326","article-title":"Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production","volume":"56","author":"Green","year":"2007","journal-title":"Arthritis rheumatism"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317707826","article-title":"The immunological personality of close relatives of SLE patients","volume":"26","author":"Salaman","year":"2017","journal-title":"Lupus"},{"key":"B94","doi-asserted-by":"publisher","first-page":"195ra96","DOI":"10.1126\/scitranslmed.3005727","article-title":"NCR3\/NKp30 contributes to pathogenesis in primary Sjogren\u2019s syndrome","volume":"5","author":"Rusakiewicz","year":"2013","journal-title":"Sci Trans Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203187","article-title":"Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren\u2019s syndrome","volume":"73","author":"Awada","year":"2014","journal-title":"Ann rheumatic diseases"},{"key":"B96","doi-asserted-by":"publisher","first-page":"98","DOI":"10.55563\/clinexprheumatol\/uzzz6d","article-title":"Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"39","author":"Zhao","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.4110\/in.2019.19.e26","article-title":"Circulating CCR7(lo)PD-1(hi) follicular helper T cells indicate disease activity and glandular inflammation in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Kim","year":"2019","journal-title":"Immune network"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1080\/03009740801910361","article-title":"Immunological alterations in newly diagnosed primary Sj\u00f6gren\u2019s syndrome characterized by skewed peripheral T-cell subsets and inflammatory cytokines","volume":"37","author":"Szodoray","year":"2008","journal-title":"Scandinavian J Rheumatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-06011-z","article-title":"Diminished natural killer T-like cells correlates with aggravated primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Zhou","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1586\/1744666x.2014.891439","article-title":"B-cell hyperactivity in primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B102","article-title":"Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sj\u00f6gren\u2019s syndrome patients","author":"van Ginkel","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.952304","article-title":"B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools","volume":"9","author":"Parodis","year":"2022","journal-title":"Front Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/art.40059","article-title":"Enhanced Bruton's tyrosine kinase activity in peripheral blood B lymphocytes from patients with autoimmune disease","volume":"69","author":"Corneth","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/art.20276","article-title":"Abnormalities in peripheral B cell memory of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"50","author":"Hansen","year":"2004","journal-title":"Arthritis rheumatism"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1080\/25785826.2019.1659476","article-title":"Plasmablasts and neuroimmunological disorders","volume":"42","author":"Chihara","year":"2019","journal-title":"Immunol Med"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.jaci.2016.01.024","article-title":"Cytometry by time-of-flight immunophenotyping identifies a blood Sj\u00f6gren\u2019s signature correlating with disease activity and glandular inflammation","volume":"137","author":"Mingueneau","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B109","article-title":"CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren\u2019s syndrome","volume":"7","author":"Jin","year":"2014","journal-title":"Int J Clin Exp pathol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2012.712170","article-title":"Low number of memory B cells in the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"45","author":"Aqrawi","year":"2012","journal-title":"Autoimmunity"},{"key":"B111","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/ar2210","article-title":"B cells in Sj\u00f6gren\u2019s syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue","volume":"9","author":"Hansen","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/art.40181","article-title":"Plasmablasts with a mucosal phenotype contribute to plasmacytosis in systemic lupus erythematosus","volume":"69","author":"Mei","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.871096","article-title":"Labial gland mesenchymal stem cell derived exosomes-mediated miRNA-125b attenuates experimental Sjogren\u2019s syndrome by targeting PRDM1 and suppressing plasma cells","volume":"13","author":"Xing","year":"2022","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfz031","article-title":"Clinical features and outcomes in a cohort of patients with immunoglobulin G4-related disease at a university hospital in Spain","volume":"12","author":"Quero","year":"2019","journal-title":"Clin Kidney J"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01141-1","article-title":"Defining two subpopulations of marginal zone B cells","volume":"21","author":"Liu","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B116","article-title":"When B cells break bad: development of pathogenic B cells in Sj\u00f6gren\u2019s syndrome","author":"Reed","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/art.21936","article-title":"Identification of transitional type II B cells in the salivary glands of patients with Sj\u00f6gren\u2019s syndrome","volume":"54","author":"Daridon","year":"2006","journal-title":"Arthritis rheumatism"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636270","article-title":"Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells","volume":"36","author":"Fletcher","year":"2006","journal-title":"Eur J Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.04.008","article-title":"Central role for marginal zone B cells in an animal model of Sjogren\u2019s syndrome","volume":"168","author":"Shen","year":"2016","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15120","article-title":"Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sj\u00f6gren syndrome (pSS)","volume":"184","author":"Demaria","year":"2019","journal-title":"Br J haematol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e12718","DOI":"10.1111\/sji.12718","article-title":"Aberrant IL-35 levels in patients with primary Sjogren\u2019s syndrome","volume":"88","author":"Guo","year":"2018","journal-title":"Scandinavian J Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-019-0227-z","article-title":"IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Lin","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684999","article-title":"The multiple roles of B cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3554","article-title":"Interleukin-35 induces regulatory B cells that suppress autoimmune disease","volume":"20","author":"Wang","year":"2014","journal-title":"Nat Med"},{"key":"B128","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jaci.2017.07.041","article-title":"Role of the IL-12\/IL-35 balance in patients with Sj\u00f6gren syndrome","volume":"142","author":"Fogel","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.217","article-title":"Ectopic lymphoid neogenesis in rheumatic autoimmune diseases","volume":"13","author":"Bombardieri","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sj\u00f6gren\u2019s syndrome","volume":"62","author":"Mariette","year":"2003","journal-title":"Ann rheumatic diseases"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/art.22458","article-title":"Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"56","author":"Daridon","year":"2007","journal-title":"Arthritis rheumatism"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902551","article-title":"Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells","volume":"184","author":"Yang","year":"2010","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.07.003","article-title":"The role of ectopic germinal centers in the immunopathology of primary Sj\u00f6gren\u2019s syndrome: a systematic review","volume":"42","author":"Risselada","year":"2013","journal-title":"Semin Arthritis rheumatism"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1038\/ni1100","article-title":"Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5","volume":"5","author":"Allen","year":"2004","journal-title":"Nat Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdsr.2019.09.006","article-title":"B cell dysregulation in primary Sj\u00f6gren\u2019s syndrome: A review","volume":"55","author":"Ibrahem","year":"2019","journal-title":"Japanese Dental Sci review"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/43z8gu","article-title":"Sj\u00f6gren\u2019s syndrome: one year in review 2022","volume":"40","author":"Manfr\u00e8","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/255qsx","article-title":"Sj\u00f6gren\u2019s syndrome: one year in review 2023","volume":"41","author":"Longhino","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102689","article-title":"New developments implicating IL-21 in autoimmune disease","volume":"122","author":"Ren","year":"2021","journal-title":"J autoimmunity"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102976","article-title":"T follicular helper cells in autoimmune diseases","volume":"134","author":"Wei","year":"2023","journal-title":"J autoimmunity"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.102364","article-title":"Sj\u00f6gren\u2019s syndrome: Old and new therapeutic targets","volume":"110","author":"Mavragani","year":"2020","journal-title":"J autoimmunity"},{"key":"B141","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40259-021-00505-7","article-title":"Targeted therapy for primary Sj\u00f6gren\u2019s syndrome: where are we now","volume":"35","author":"Wang","year":"2021","journal-title":"BioDrugs"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/art.40479","article-title":"Brief report: A randomized, double-blind, parallel-group, placebo-controlled, multiple-dose study to evaluate AMG 557 in patients with systemic lupus erythematosus and active lupus arthritis","volume":"70","author":"Cheng","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00806","article-title":"Pharmacodynamic monitoring of RO5459072, a small molecule inhibitor of Cathepsin S","volume":"8","author":"Theron","year":"2017","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead092","article-title":"A randomized, double-blind, placebo-controlled, parallel group study on the effects of a cathepsin S inhibitor in primary Sj\u00f6gren\u2019s syndrome","volume":"62","author":"Bentley","year":"2023","journal-title":"Rheumatol (Oxford England)"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225069","article-title":"CD8(+) tissue-resident memory T cells are expanded in primary Sj\u00f6gren\u2019s disease and can be therapeutically targeted by CD103 blockade","author":"Mauro","year":"2024","journal-title":"Ann rheumatic Dis"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1002\/art.20472","article-title":"Effective treatment of a mouse model of Sj\u00f6gren\u2019s syndrome with eyedrop administration of anti-CD4 monoclonal antibody","volume":"50","author":"Hayashi","year":"2004","journal-title":"Arthritis rheumatism"},{"key":"B147","doi-asserted-by":"publisher","first-page":"R44","DOI":"10.1186\/ar2403","article-title":"Mucosal administration of alpha-fodrin inhibits experimental Sj\u00f6gren\u2019s syndrome autoimmunity","volume":"10","author":"He","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02372-z","article-title":"Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients","volume":"23","author":"Marken","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"B149","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/jpet.121.000881","article-title":"Preclinical immunopharmacologic assessment of KPL-404, a novel, humanized, non-depleting antagonistic anti-CD40 monoclonal antibody","volume":"381","author":"Muralidharan","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.731122","article-title":"Rituximab therapy for primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1002\/art.42772","article-title":"Serum and tissue biomarkers associated with composite of relevant endpoints for Sj\u00f6gren syndrome (CRESS) and Sj\u00f6gren tool for assessing response (STAR) to B cell-targeted therapy in the trial of anti-B cell therapy in patients with primary Sj\u00f6gren syndrome (TRACTISS)","volume":"76","author":"Pontarini","year":"2024","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2018.1450141","article-title":"Epratuzumab for the treatment of systemic lupus erythematosus","volume":"14","author":"Geh","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02661","article-title":"Ly9 (CD229) antibody targeting depletes marginal zone and germinal center B cells in lymphoid tissues and reduces salivary gland inflammation in a mouse model of Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Pu\u00f1et-Ortiz","year":"2018","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.04.010","article-title":"Anti-IL-7 receptor-\u03b1 treatment ameliorates newly established Sj\u00f6gren\u2019s-like exocrinopathy in non-obese diabetic mice","volume":"1864","author":"Zhou","year":"2018","journal-title":"Biochim Biophys Acta Mol basis disease"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren\u2019s syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann rheumatic diseases"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev005","article-title":"Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren\u2019s syndrome","volume":"54","author":"Pontarini","year":"2015","journal-title":"Rheumatol (Oxford England)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev257","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren\u2019s syndrome: the BELISS open-label phase II study","volume":"54","author":"De Vita","year":"2015","journal-title":"Rheumatol (Oxford England)"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214720","article-title":"Treatment of primary Sj\u00f6gren\u2019s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity","volume":"78","author":"D\u00f6rner","year":"2019","journal-title":"Ann rheumatic diseases"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01288-7","article-title":"Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sj\u00f6gren\u2019s syndrome in mice by promoting TEC kinase degradation","volume":"45","author":"Yang","year":"2024","journal-title":"Acta pharmacologica Sin"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1080\/1744666x.2019.1624527","article-title":"Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sj\u00f6gren\u2019s syndrome","volume":"15","author":"van der Heijden","year":"2019","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1468469\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T04:37:29Z","timestamp":1725338249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1468469\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2024.1468469"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1468469","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"article-number":"1468469"}}